Similarly, increased Ifng mRNA and IFN-γ protein levels were observed in tumors from hsBCL9z96-treated CT26 tumor-bearing mice and MC38 tumor-bearing Bcl9/Bcl9l deficiency mice (Fig. 7b, c). Here, BCL9L is linked to neoplasm.